<DOC>
	<DOCNO>NCT00577655</DOCNO>
	<brief_summary>The primary objective study evaluate chronic-dose efficacy Albuterol-HFA-MDI relative placebo pediatric asthmatic .</brief_summary>
	<brief_title>Albuterol HFA MDI Pediatric Participants With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Male female child age 411 year , inclusive Asthma minimum six month duration stable least four week prior screen . Hospitalization acute asthma exacerbation great two year 12 month prior screen and/or receive ER treatment hospitalization asthma exacerbation .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Pediatric , asthma , albuterol-HFA Placebo</keyword>
</DOC>